Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | PLK1 | P53350 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CRY1 | Q16526 | 4/20 | 0.35 |
| ▸ | CRY2 | Q49AN0 | 4/20 | 0.35 |
| ▸ | PER2 | O15055 | 3/20 | 0.35 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.35 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.35 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6738280 | 0.90 | CYP2C9 (0.65) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6236224 | 0.89 | CYP2C9 (0.80) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6736069 | 0.89 | CYP2C9 (0.82) | CYP2C9NR1I2MAPK1HSD17B10PLA2G2A | |
| SCHEMBL6739021 | 0.89 | CYP2C9 (0.64) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6685191 | 0.84 | CYP2C9 (0.64) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6736597 | 0.79 | CYP2C9 (0.76) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6688517 | 0.79 | CYP2C9 (0.88) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6688520 | 0.79 | CYP2C9 (0.88) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6232681 | 0.79 | CYP2C9 (0.88) | CYP2C9NR1I2MAPK1HSD17B10PLK1 | |
| SCHEMBL6255910 | 0.79 | CYP2C9 (0.80) | CYP2C9NR1I2MAPK1HSD17B10PLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040147739-A1 | Novel anti-infectives | SMITHKLINE BEECHAM CORPORATION | 2004-07-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147739-A1 | Novel anti-infectives | RPL5, RPL7, RPL35 | CYP2C9 1218/4885NR1I2 1798/4885MAPK1 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.